{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:05:00Z","timestamp":1778533500933,"version":"3.51.4"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["101016167"],"award-info":[{"award-number":["101016167"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Households are a major driver of transmission of acute respiratory viruses, such as SARS-CoV-2 or Influenza. Until now antiviral treatments have mostly been used as a curative treatment in symptomatic individuals. During an outbreak, more aggressive strategies involving pre- or post-exposure prophylaxis (PrEP or PEP) could be employed to further reduce the risk of severe disease but also prevent transmission to household contacts. In order to understand the effectiveness of such strategies and the factors that may modulate them, we developed a multi-scale model that follows the infection at both the individual-level (viral dynamics) and the population-level (transmission dynamics) in households. Using a simulation study we explored different antiviral treatment strategies, evaluating their effectiveness on reducing the transmission risk and the virological burden in households for a range of virus characteristics (e.g., secondary attack rate\u2014SAR, or time to peak viral load). We found that when the index case can be identified and treated before symptom onset, both transmission and virological burden are reduced by &gt; 75% for most SAR values and time to peak viral load, with minimal benefit to treat additionally household contacts. While treatment initiated after index symptom onset does not reduce the risk of transmission, it can still reduce the virological burden in the household, a proxy for severe disease and subsequent transmission risk outside the household. In that case optimal strategies involve treatment of both index case and household contacts as PEP, with efficacy &gt; 50% when peak viral load occurs after symptom onset, and 30-50% otherwise. In all the considered cases, antiviral treatment strategies were optimal for SAR ranging 20-60%, and for larger household sizes. This study highlights the opportunity of antiviral drug-based interventions in households during an outbreak to minimize viral transmission and disease burden.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1012573","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T18:26:17Z","timestamp":1733423177000},"page":"e1012573","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Modelling the effectiveness of antiviral treatment strategies to prevent household transmission of acute respiratory viruses"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-1898","authenticated-orcid":true,"given":"Hind","family":"Zaaraoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisse","family":"Schumer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Duval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Hoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulla","family":"Opatowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5534-5482","authenticated-orcid":true,"given":"J\u00e9r\u00e9mie","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"pcbi.1012573.ref001","doi-asserted-by":"crossref","first-page":"100148","DOI":"10.1016\/j.lanepe.2021.100148","article-title":"Exposures associated with SARS-CoV-2 infection in France: a nationwide online case-control study","volume":"7","author":"S Galmiche","year":"2021","journal-title":"The Lancet Regional Health-Europe"},{"key":"pcbi.1012573.ref002","article-title":"An explanation for SARS-CoV-2 rebound after Paxlovid treatment","author":"AS Perelson","year":"2023","journal-title":"MedRxiv"},{"issue":"1","key":"pcbi.1012573.ref003","first-page":"1","article-title":"Insights into household transmission of SARS-CoV-2 from a population-based serological survey","volume":"12","author":"Q Bi","year":"2021","journal-title":"Nature communications"},{"issue":"7","key":"pcbi.1012573.ref004","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/aje\/kwac042","article-title":"Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study","volume":"191","author":"M Layan","year":"2022","journal-title":"American journal of epidemiology"},{"issue":"21","key":"pcbi.1012573.ref005","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMoa1413275","article-title":"Activity of oral ALS-008176 in a respiratory syncytial virus challenge study","volume":"373","author":"JP DeVincenzo","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"pcbi.1012573.ref006","doi-asserted-by":"crossref","first-page":"e2031756","DOI":"10.1001\/jamanetworkopen.2020.31756","article-title":"Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis","volume":"3","author":"ZJ Madewell","year":"2020","journal-title":"JAMA network open"},{"issue":"10","key":"pcbi.1012573.ref007","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3201\/eid2810.220494","article-title":"SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain","volume":"28","author":"I L\u00f3pez-Mu\u00f1oz","year":"2022","journal-title":"Emerging infectious diseases"},{"issue":"7","key":"pcbi.1012573.ref008","doi-asserted-by":"crossref","first-page":"e1003660","DOI":"10.1371\/journal.pmed.1003660","article-title":"Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study","volume":"18","author":"S Iwanami","year":"2021","journal-title":"PLoS medicine"},{"key":"pcbi.1012573.ref009","article-title":"Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large US Health System: A Population-Based Cohort Study","author":"S Dryden-Peterson","year":"2022","journal-title":"Annals of Internal Medicine"},{"key":"pcbi.1012573.ref010","article-title":"Intramuscular AZD7442 (tixagevimab\u2013cilgavimab) for prevention of COVID-19","author":"MJ Levin","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"13","key":"pcbi.1012573.ref011","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMoa2109682","article-title":"Subcutaneous REGEN-COV antibody combination to prevent Covid-19","volume":"385","author":"MP O\u2019Brien","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"pcbi.1012573.ref012","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"J Hammond","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"pcbi.1012573.ref013","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3201\/eid\/1706.101161","article-title":"Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom","volume":"17","author":"RG Pebody","year":"2011","journal-title":"Emerging infectious diseases"},{"key":"pcbi.1012573.ref014","unstructured":"UK Health Security Agency. Guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza. 2021"},{"issue":"9","key":"pcbi.1012573.ref015","first-page":"509","article-title":"Timing of antiviral treatment initiation is critical to reduce SARS\u2010CoV\u20102 viral load","volume":"9","author":"A Gon\u00e7alves","year":"2020","journal-title":"CPT: pharmacometrics and systems pharmacology"},{"issue":"23","key":"pcbi.1012573.ref016","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1056\/NEJMoa2108163","article-title":"REGEN-COV antibody combination and outcomes in outpatients with Covid-19","volume":"385","author":"DM Weinreich","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"pcbi.1012573.ref017","doi-asserted-by":"crossref","first-page":"e81849","DOI":"10.7554\/eLife.81849","article-title":"Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study","volume":"11","author":"JA Hay","year":"2022","journal-title":"eLife"},{"issue":"9","key":"pcbi.1012573.ref018","doi-asserted-by":"crossref","first-page":"e176286","DOI":"10.1172\/jci.insight.176286","article-title":"Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses","volume":"9","author":"K Owens","year":"2024","journal-title":"JCI Insight"},{"issue":"10","key":"pcbi.1012573.ref019","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1473-3099(20)30471-0","article-title":"Household Secondary Attack Rate of COVID-19 and Associated Determinants","volume":"20","author":"QL Jing","year":"2020","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"pcbi.1012573.ref020","first-page":"429","article-title":"Influenza A virus infection kinetics: quantitative data and models","volume":"3","author":"AM Smith","year":"2011","journal-title":"Wiley Interdisciplinary Reviews: Systems Biology and Medicine"},{"issue":"8","key":"pcbi.1012573.ref021","doi-asserted-by":"crossref","first-page":"e2017962118","DOI":"10.1073\/pnas.2017962118","article-title":"Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort","volume":"118","author":"N N\u00e9ant","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"pcbi.1012573.ref022","article-title":"Viral kinetics in COVID-19 outpatients treated with CASIRIVIMAB+IMDEVIMAB combination","author":"JD Conrado","year":"2022","journal-title":"Conference on Retroviruses and Opportunistic Infections"},{"issue":"1","key":"pcbi.1012573.ref023","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","article-title":"SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis","volume":"2","author":"M Cevik","year":"2021","journal-title":"The lancet microbe"},{"issue":"49","key":"pcbi.1012573.ref024","doi-asserted-by":"crossref","first-page":"e2111477118","DOI":"10.1073\/pnas.2111477118","article-title":"In vivo kinetics of SARS-CoV-2 infection and its relationship with a person\u2019s infectiousness","volume":"118","author":"R Ke","year":"2021","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"pcbi.1012573.ref025","doi-asserted-by":"crossref","first-page":"e69302","DOI":"10.7554\/eLife.69302","article-title":"Quantifying the relationship between SARS-CoV-2 viral load and infectiousness","volume":"10","author":"A Marc","year":"2021","journal-title":"Elife"},{"issue":"8","key":"pcbi.1012573.ref026","doi-asserted-by":"crossref","first-page":"e2228008","DOI":"10.1001\/jamanetworkopen.2022.28008","article-title":"Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis","volume":"5","author":"Y Wu","year":"2022","journal-title":"JAMA network open"},{"issue":"5","key":"pcbi.1012573.ref027","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1473-3099(20)30981-6","article-title":"Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study","volume":"21","author":"F Li","year":"2021","journal-title":"The Lancet Infectious Diseases"},{"key":"pcbi.1012573.ref028","article-title":"Transmission dynamics of COVID-19 in household and community settings in the United Kingdom","author":"JL Bernal","year":"2020","journal-title":"MedRxiv"},{"issue":"2","key":"pcbi.1012573.ref029","first-page":"64","article-title":"COVID-19 secondary attack rate and risk factors in household contacts in Castellon (Spain): Preliminary report","volume":"19","author":"A Arnedo-Pena","year":"2020","journal-title":"Enfermedades Emergentes"},{"key":"pcbi.1012573.ref030","doi-asserted-by":"crossref","first-page":"100014","DOI":"10.1016\/j.lanepe.2020.100014","article-title":"Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: a case-ascertained study","volume":"3","author":"K Kuwelker","year":"2021","journal-title":"The Lancet Regional Health-Europe"},{"issue":"1","key":"pcbi.1012573.ref031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jinf.2020.03.040","article-title":"Household transmission of SARS-CoV-2","volume":"81","author":"Z Wang","year":"2020","journal-title":"Journal of Infection"},{"key":"pcbi.1012573.ref032","article-title":"Household secondary attack rate of COVID-19 by household size and index case characteristics","author":"S Tibebu","year":"2021","journal-title":"MedRxiv"},{"key":"pcbi.1012573.ref033","unstructured":"INSEE. https:\/\/www.insee.fr\/fr\/statistiques\/2381486#tableau-figure1_radio1. 2016"},{"issue":"15","key":"pcbi.1012573.ref034","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1128\/JVI.01623-05","article-title":"Kinetics of influenza A virus infection in humans","volume":"80","author":"P Baccam","year":"2006","journal-title":"Journal of virology"},{"issue":"1","key":"pcbi.1012573.ref035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3201\/eid1201.051370","article-title":"Nonpharmaceutical interventions for pandemic influenza, international measures. Emerging infectious diseases","volume":"12","author":"Group, World Health Organization Writing","year":"2006","journal-title":"Emerging infectious diseases"},{"issue":"7","key":"pcbi.1012573.ref036","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/aje\/kwm375","article-title":"Time lines of infection and disease in human influenza: a review of volunteer challenge studies","volume":"167","author":"F Carrat","year":"2008","journal-title":"American journal of epidemiology"},{"issue":"48","key":"pcbi.1012573.ref037","doi-asserted-by":"crossref","first-page":"2001636","DOI":"10.2807\/1560-7917.ES.2021.26.48.2001636","article-title":"Lockdown impact on age-specific contact patterns and behaviours, France, April 2020","volume":"26","author":"P Bosetti","year":"2021","journal-title":"Eurosurveillance"},{"issue":"9","key":"pcbi.1012573.ref038","doi-asserted-by":"crossref","first-page":"e1005697","DOI":"10.1371\/journal.pcbi.1005697","article-title":"Projecting social contact matrices in 152 countries using contact surveys and demographic data","volume":"13","author":"K Prem","year":"2017","journal-title":"PLoS computational biology"},{"issue":"10","key":"pcbi.1012573.ref039","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/jamainternmed.2021.4686","article-title":"COVID-19 transmission dynamics among close contacts of index patients with COVID-19: a population-based cohort study in Zhejiang province, China","volume":"181","author":"Y Ge","year":"2021","journal-title":"JAMA Internal Medicine"},{"issue":"2","key":"pcbi.1012573.ref040","article-title":"COVID-19 in children and the dynamics of infection in families","volume":"146","author":"KM Posfay-Barbe","year":"2020","journal-title":"Pediatrics"},{"key":"pcbi.1012573.ref041","article-title":"SARS-CoV-2 transmission dynamics in households with children, Los Angeles, California","volume":"1520","author":"ML Tanaka","year":"2022","journal-title":"Frontiers in pediatrics"},{"issue":"6","key":"pcbi.1012573.ref042","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19","volume":"383","author":"DR Boulware","year":"2020","journal-title":"New England journal of medicine"},{"key":"pcbi.1012573.ref043","first-page":"1","article-title":"SARS-CoV-2 viral load and shedding kinetics","author":"O Puhach","year":"2022","journal-title":"Nature Reviews Microbiology"},{"key":"pcbi.1012573.ref044","first-page":"ciac899","article-title":"AZD7442 (Tixagevimab\/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019","author":"MJ Levin","year":"2022","journal-title":"Clinical infectious diseases"},{"issue":"2","key":"pcbi.1012573.ref045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tim.2015.10.012","article-title":"Household transmission of influenza virus","volume":"24","author":"TK Tsang","year":"2016","journal-title":"Trends in microbiology"},{"issue":"5","key":"pcbi.1012573.ref046","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41591-022-01780-9","article-title":"Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults","volume":"28","author":"B Killingley","year":"2022","journal-title":"Nature Medicine"},{"issue":"6507","key":"pcbi.1012573.ref047","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.abc9004","article-title":"Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions","volume":"369","author":"ST Ali","year":"2020","journal-title":"Science"},{"key":"pcbi.1012573.ref048","doi-asserted-by":"crossref","first-page":"100446","DOI":"10.1016\/j.lanepe.2022.100446","article-title":"Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission","volume":"19","author":"M Manica","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"pcbi.1012573.ref049","doi-asserted-by":"crossref","first-page":"e70767","DOI":"10.7554\/eLife.70767","article-title":"Inference of the SARS-CoV-2 generation time using UK household data","volume":"11","author":"WS Hart","year":"2022","journal-title":"Elife"},{"key":"pcbi.1012573.ref050","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1017\/S0950268822001947","article-title":"Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data","volume":"151","author":"M Manica","year":"2022","journal-title":"Epidemiol Infect"},{"issue":"5","key":"pcbi.1012573.ref051","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/jac\/dkac048","article-title":"Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial","volume":"77","author":"G Lingas","year":"2022","journal-title":"Journal of Antimicrobial Chemotherapy"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T18:26:42Z","timestamp":1733423202000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012573"}},"subtitle":[],"editor":[{"given":"Eric HY","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1012573","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]}}}